Introduction Neuroendocrine neoplasms (NEN) are heterogeneous malignancies that can
arise at almost any anatomical site and are classified as biologically distinct well …

Neuroendocrine neoplasms (NENs) are derived from neuroendocrine cell system and can
have benign or malignant characteristics. They are rare tumors, but have been increasing in …

Background Surufatinib showed superior efficacy in extrapancreatic neuroendocrine
tumours (NETs) in the phase 3 SANET-ep study. In SANET-p, we aimed to assess the …

Background Neuroendocrine neoplasia (NEN) incidence is rising internationally. We aimed
to evaluate the epidemiology of NEN in England and examine changes in survival over time …

Background To investigate the recent epidemiological trends of gastric neuroendocrine
neoplasms (GNENs) and establish a new tool to estimate the prognosis of gastric …

Background The incidence of early-onset (diagnosis before age 50) colorectal cancer (EO-
CRC) is increasing in some high-income countries. The present study analyzed this trend in …

Opinion statement Treatment recommendations for advanced gastroenteropancreatic
neuroendocrine carcinomas (GEP-NEC) are based on uncontrolled, mainly retrospective …

Neuroendocrine tumors (NETs) are rare heterogeneous tumors that are often misdiagnosed
and mistreated. Most NETs patients are diagnosed as advanced. Early on-time detection of …

Neuroendocrine tumors (NETs) are rare, heterogeneous, often indolent tumors that
predominantly originate in the lungs and gastrointestinal tract. An understanding of the …

Neuroendocrine tumors (NETs) are an uncommon, heterogeneous group of tumors arising
from cells of neuroendocrine origin, which can be found at multiple sites throughout the …